*Undisclosed Targets
Activated by tumor specific glycolytic metabolism
Antibodies, immunocytokines & fusion proteins
Significantly reduced off-tumor and off-target toxicity
Mono- or multi-specific targeting of immune and/or tumor cells
At Amberstone, we are constantly striving to bring our technologies and platform into more realms of therapeutic research. We welcome the opportunity for new partnerships and alliances that can further our goals in discovering next-generation therapeutic biologics.